Direct treatment-cost of patients with rheumatoid arthritis in Medellín, Colombia

Objective to analyze clinical variables and direct costs of a sample of patients with rheumatoid arthritis from a specialized pharmacotherapeutic management center in Medellin, Colombia. Methods we reviewed 408 clinical files of the period 2007-2009 collecting clinical information and direct costs to a local private health insurer. Results 337 women (82.6%), average age 49.8 (range 4-91). Average monthly cost increased from Col$1.31 million (around US$650) in 2007, to Col$1.71 million (~US$850) in 2008, and Col$1.99 million (~US$1000) in 2009; 87.9% of this cost represented by pharmaceuticals. Conclusions costs of treatment are increasing, pharmaceuticals represent an important proportion of total cost.